Survivorship News

Patients with early-stage classic Hodgkin lymphoma and other neoplasms exhibited higher risk for cardiovascular disease-associated mortality compared with cancer-associated mortality later in life, according to study results.

Menopausal hormone therapy or vaginal estrogen therapy did not appear associated with increased risk for breast cancer recurrence or mortality among postmenopausal women with early-stage, ER-positive disease, according to study results.

Cancer treatment is often focused on the immediate goal of curing or managing the disease.

Advances in cancer treatment during the past half-century have achieved one of the fundamental goals of oncology: longer survival.

As the number of cancer survivors in the U.S. tops 18 million, ensuring quality care for this aging population remains a challenge, according to a study published in CA: A Cancer Journal for Clinicians.

CHICAGO – Healio gathered the best, brightest and boldest group of oncologists during the ASCO Annual Meeting in Chicago to celebrate our inaugural Healio Disruptive Innovators.

Adult survivors of childhood cancer were more likely be undertreated for CVD risk factors, particularly hypertension and dyslipidemia, compared with controls, according to data published in the Journal of the American Heart Association.

CHICAGO — During the ASCO Annual Meeting, Healio honored our inaugural Healio Disruptive Innovators in hematology/oncology.

THOROFARE, NJ — Healio is set to host the inaugural hematology/oncology Disruptive Innovators Award Reception during the American Society of Clinical Oncology Annual Meeting. The event will take place on June 4, 2022, at the Hyatt Regency McCormick Place in Chicago, Illinois.

Death due to a second primary cancer occurred nearly twice as often among adolescent and young adult cancer survivors compared with the general population, according to study results published in Journal of the National Cancer Institute.